IP Library Granted Patent US 10,583,168
Granted Patent B1
US 10,583,168 · App. 15/854,612 · Granted Mar 10, 2020

Nutritional supplements including cardiovascular support components

Inventor: William J. Hennen (Provo, UT)
Assignee: 4Life Patents, LLC
A61K38/17A61K31/198A61K31/465A61K35/20A61K38/1709A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,583,168
App. No.
15/854,612
Granted
Mar 10, 2020
Kind
B1
Abstract

A composition for use in cardiovascular support includes transfer factor. The transfer factor may be nonmammalian transfer factor, such as that derived from eggs, or mammalian transfer factor, such as that derived from colostrum. The composition may also include one or more of the following: an LDL receptor-binding element; a blood flow-enhancing element; a cholesterol reducing element; a fat oxidation prevention element, and an antioxidant. Treatment methods include enlisting the immune system of a subject receiving therapy to attack pathogens that cause inflammation of blood vessels or to otherwise reduce inflammation of blood vessels.

Claims (39)

1. A nutritional supplement, comprising:

a cardiovascular support component, consisting of:

an inflammation-reducing component for decreasing an amount of inflammation in blood vessels of a subject, comprising transfer factor;

at least one low density lipoprotein (LDL) receptor-binding component;

at least one blood cholesterol reduction component;

at least one blood flow-enhancing component; and

at least one antioxidant.

2. The nutritional supplement of claim 1 , wherein the transfer factor is at least one of an extract from a mammalian source and an extract from a nonmammalian source.

3. The nutritional supplement of claim 1 , wherein the transfer factor is specific for at least one pathogen that directly causes a cardiovascular disorder or for at least one antigen of at least one pathogen that causes the cardiovascular disorder.

4. The nutritional supplement of claim 1 , wherein the at least one low density lipoprotein (LDL) receptor-binding component is lysine or a lysine salt.

5. The nutritional supplement of claim 1 , wherein the at least one blood flow-enhancing component is at least one of an arginine-containing compound and niacinamide.

6. The nutritional supplement of claim 1 , wherein the at least one antioxidant is a hydrophobic antioxidant.

7. The nutritional supplement of claim 6 , wherein the hydrophobic antioxidant is at least one of beta-carotene, vitamin A, and vitamin E.

8. The nutritional supplement of claim 1 , wherein the at least one antioxidant is Coenzyme Q 10 .

9. The nutritional supplement of claim 1 , further comprising:

at least one herb or plant extract selected from the group comprising Butcher's Broom, Ginkgo biloba , hawthorn, garlic, red rice yeast extract, resveratrol and ginger.

10. The nutritional supplement of claim 9 , wherein the at least one herb or plant extract is a fat oxidation prevention element.

11. A nutritional supplement, comprising:

a cardiovascular support component, consisting of:

a pathogen-reducing component for decreasing a number of pathogens in blood vessels of a subject; and

at least one blood flow-enhancing component.

12. The nutritional supplement of claim 11 , wherein the pathogen-reducing component comprises transfer factor.

13. The nutritional supplement of claim 12 , wherein the transfer factor is specific for at least one pathogen that directly causes a cardiovascular disorder or for at least one antigen of at least one pathogen that causes the cardiovascular disorder.

14. The nutritional supplement of claim 11 , wherein the at least one blood flow-enhancing component is at least one of an arginine-containing compound and niacinamide.

15. The nutritional supplement of claim 11 , further comprising:

at least one mineral comprising part of an LDL receptor-binding component.

16. The nutritional supplement of claim 15 , wherein the LDL receptor-binding component is a lysine salt of the at least one mineral.

17. A nutritional supplement, comprising:

a cardiovascular support component, consisting of:

a transfer factor preparation;

Vitamin C;

niacinamide;

an arginine-containing compound; and

a lysine-containing compound.

18. The nutritional supplement of claim 17 , wherein:

the arginine-containing compound comprises magnesium arginate; and

the lysine-containing compound comprises magnesium lysinate.

19. The nutritional supplement of claim 17 , comprising the transfer factor preparation and the Vitamin C in substantially equal amounts.

20. The nutritional supplement of claim 17 , wherein the transfer factor preparation is specific for at least one pathogen that directly causes a cardiovascular disorder or for at least one antigen of at least one pathogen that causes a cardiovascular disorder.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2018
From: HENNEN, WILLIAM J., PHD
To: 4LIFE RESEARCH, LC
Reel/Frame 046427/0458 →
CHANGE OF NAME Recorded Jul 23, 2018
From: 4LIFE RESEARCH, LC
To: 4LIFE RESEARCH, LLC
Reel/Frame 046427/0800 →
NUNC PRO TUNC ASSIGNMENT Recorded Jul 23, 2018
From: 4LIFE RESEARCH, LLC
To: 4LIFE PATENTS, LLC
Reel/Frame 046427/0931 →
Continuity (3)
Continuation 12906883 · Oct 18, 2010
Continuation 10646615 · Aug 22, 2003
Provisional Application 60405358 · Aug 22, 2002